Advanced Enzyme Technologies Limited

Symbol: ADVENZYMES.NS

NSE

387.45

INR

Market price today

  • 32.0302

    P/E Ratio

  • 0.2020

    PEG Ratio

  • 43.33B

    MRK Cap

  • 0.01%

    DIV Yield

Advanced Enzyme Technologies Limited (ADVENZYMES-NS) Financial Statements

On the chart you can see the default numbers in dynamics for Advanced Enzyme Technologies Limited (ADVENZYMES.NS). Companys revenue shows the average of 3371.855 M which is 0.139 % gowth. The average gross profit for the whole period is 2572.887 M which is 0.182 %. The average gross profit ratio is 0.744 %. The net income growth for the company last year performance is -0.117 % which equals 0.285 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Advanced Enzyme Technologies Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.100. In the realm of current assets, ADVENZYMES.NS clocks in at 7210.56 in the reporting currency. A significant portion of these assets, precisely 4858.26, is held in cash and short-term investments. This segment shows a change of 0.300% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 1.7, if any, in the reporting currency. This indicates a difference of 142.857% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 223.77 in the reporting currency. This figure signifies a year_over_year change of 0.258%. Shareholder value, as depicted by the total shareholder equity, is valued at 12350.69 in the reporting currency. The year over year change in this aspect is 0.135%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 1004.56, with an inventory valuation of 1239.9, and goodwill valued at 3208.53, if any. The total intangible assets, if present, are valued at 608.78.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010

balance-sheet.row.cash-and-short-term-investments

14248.794858.33737.43167
2076.3
1352.6
627
78.7
263.1
43.4
26.5
37
53
148.8

balance-sheet.row.short-term-investments

7608.933894.11063.81247.8
1249.7
1122
15.8
0
-180.4
-160.3
-170.1
0
0
0

balance-sheet.row.net-receivables

2125.931004.61052.21051.1
868.2
648.1
749
705.7
510.8
471
393.8
454.9
423.8
311

balance-sheet.row.inventory

2596.151239.91209.2938.8
800.3
769
755.7
684.8
604.9
526.3
499.3
445.9
290.8
178.7

balance-sheet.row.other-current-assets

273.14107.84.73.8
10.9
51
23.5
0.3
18.3
0.4
0.6
0.3
0
0.1

balance-sheet.row.total-current-assets

19244.017210.66003.55160.6
3755.7
2820.6
2155.3
1469.6
1397.2
1041.1
920.2
938
767.6
638.5

balance-sheet.row.property-plant-equipment-net

5787.272888.22718.82432.4
2143.3
1665.2
1693.2
1532
1162
1164.4
1173.3
1179.4
1098.6
700.5

balance-sheet.row.goodwill

6443.553208.52960.62900.8
2941.3
2714.7
2584.2
2496.6
1710.4
1710.4
1710.4
1709.5
1547.2
0

balance-sheet.row.intangible-assets

1174.93608.8663.1778.7
645.4
679.7
741
66.9
51.1
38.3
0.1
0.2
0.6
1.9

balance-sheet.row.goodwill-and-intangible-assets

7618.483817.33623.73679.4
3586.7
3394.4
3325.2
2563.5
1761.5
1748.7
1710.5
1709.7
1547.8
1.9

balance-sheet.row.long-term-investments

-3666.411.70.70.7
0.7
0.7
-15.1
0.6
181.1
161
170.7
0
0
0

balance-sheet.row.tax-assets

227.1113.474.268.7
74.2
59.1
42.4
7.3
2
43.6
84.8
0
0
0

balance-sheet.row.other-non-current-assets

4123.43187.3255.9184.9
225.4
170.9
115.6
192.7
1.3
0.4
1.1
133.2
79.4
198.8

balance-sheet.row.total-non-current-assets

14089.877007.96673.36366.2
6030.3
5290.3
5161.2
4296.1
3107.9
3118
3140.3
3022.3
2725.9
901.2

balance-sheet.row.other-assets

00-0.7-0.1
0
0
0
0
0
0
0.2
0
0
0

balance-sheet.row.total-assets

28657.6314218.512676.111526.7
9786.1
8110.9
7316.4
5765.6
4505.1
4159.1
4060.7
3960.3
3493.4
1539.7

balance-sheet.row.account-payables

505.11242.2179152.2
96.4
96.8
174.7
110.1
123.4
116.9
104.8
170
183.1
83.6

balance-sheet.row.short-term-debt

285.04111.282.5141.7
214
279.8
458.7
342.8
625.9
610.2
787.8
676.3
670.1
281.4

balance-sheet.row.tax-payables

48.0714.821.9
4.1
24.5
23.9
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

438.56223.8264.8134.4
119.8
70.5
198.3
197.4
387.5
540
879.1
1167.2
1393.9
370.1

Deferred Revenue Non Current

77.8377.884.213.6
108.8
127.7
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

729.48---
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

201.88105.297.8130.1
553.8
608.1
371.6
8.3
4.7
3.8
13.1
14.3
5.7
8.4

balance-sheet.row.total-non-current-liabilities

1178.92601.1668543.5
516.1
411.7
470.8
387.9
563.1
687.7
1024
1299.6
1461.8
440.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

384.17202.6237.985.5
134.1
0
0
0
0
0
0
0
8.7
10.9

balance-sheet.row.total-liab

2828.571376.81272.21219
1111.6
1062.9
1499.7
1040.5
1670.8
1994.8
2350.2
2301
2509.4
894.4

balance-sheet.row.preferred-stock

0000
9270.6
7462.2
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

447.3223.7223.6223.5
223.4
223.3
223.3
223.3
217.7
217.7
217.7
217.7
207.3
207.3

balance-sheet.row.retained-earnings

10022.7710022.890737978.2
6574.5
5376
4332.2
3446.1
2531.9
1820.8
1334.9
1155.8
714.8
401.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

1282.961283775.8719.1
-835.3
-635
-484.9
-938.4
-720.8
-621.9
-560.8
-461.4
-387.7
-349

balance-sheet.row.other-total-stockholders-equity

13080.48821.3813.6785.8
-6836.7
-5638
1520.3
1870.7
752
703.2
682.5
721.7
433.8
373.1

balance-sheet.row.total-stockholders-equity

24833.5112350.710885.99706.6
8396.5
6788.4
5590.8
4601.6
2780.9
2119.8
1674.3
1633.8
968.2
632.8

balance-sheet.row.total-liabilities-and-stockholders-equity

28657.6314218.512676.111526.7
9786.1
8110.9
7316.4
5765.6
4505.1
4159.1
4060.7
3960.3
3493.4
1539.7

balance-sheet.row.minority-interest

995.55491517.9601.1
277.9
259.6
226
123.5
53.5
44.5
36.3
25.5
15.9
12.6

balance-sheet.row.total-equity

25829.0612841.711403.910307.7
8674.5
7048.1
5816.8
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

28657.63---
-
-
-
-
-
-
-
-
-
-

Total Investments

90.1143.40.70.7
0.7
0.7
0.7
0.6
0.6
0.6
0.6
0.6
0.6
0.6

balance-sheet.row.total-debt

723.6335347.3276.1
333.8
350.3
657.1
540.2
1013.5
1150.2
1666.9
1843.5
2064
651.4

balance-sheet.row.net-debt

-1240.01-629.2-2326.3-1643
-492.8
119.7
45.8
461.5
750.3
1106.9
1640.5
1806.6
2011
502.7

Cash Flow Statement

The financial landscape of Advanced Enzyme Technologies Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.343. The company recently extended its share capital by issuing 1.42, marking a difference of 0.022 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -2981810000.000 in the reporting currency. This is a shift of 10.969 from the previous year. In the same period, the company recorded 350.29, 81.74, and -3.22, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -125.42 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -68, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010

cash-flows.row.net-income

1371.151403.91710.62103.7
1791.5
1619.6
1389.7
1365.8
1181.8
748.1
284.5
773.2
475.8
190.9

cash-flows.row.depreciation-and-amortization

344.14350.3349.8284.1
257.8
211.2
183
122.1
87.2
90.2
99.8
74.3
55
49.8

cash-flows.row.deferred-income-tax

000-578.8
-515.5
-473.4
-425.5
-497.9
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0003.8
8.9
14.1
24.5
3
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-3.4-274-150.3
-156
-121
-56.4
44.4
-87.5
-119
258.1
-260.7
367.4
-194.5

cash-flows.row.account-receivables

0-99.5-14-72.2
-139.1
-85.2
0
0
0
0
0
0
0
0

cash-flows.row.inventory

07.5-260.9-81.8
-5.2
-2.2
-38
-36.1
-78.6
-27
-53.5
-155.1
-112.1
82.8

cash-flows.row.account-payables

060.32814.7
-6.8
-77.3
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

028.3-27-11
-4.9
43.6
-18.4
80.4
-8.9
-92
311.6
-105.6
479.5
-277.3

cash-flows.row.other-non-cash-items

-1027.01-347.1-563.5-33.7
22.2
35.1
44.4
-461.8
-204
-181.9
-86.8
-175.6
7.3
-34.5

cash-flows.row.net-cash-provided-by-operating-activities

688.28000
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-381.8-281.8-195.8
-506.5
-123.9
-109.5
-118.3
-98.2
-126.1
-95.9
-312.4
-2004.3
-251.4

cash-flows.row.acquisitions-net

0-65.5-218.6-16.3
2
-17.5
-676
-498.1
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-2681.7-213.6-58.9
-10.2
-1110.3
-0.1
-2.4
-0.9
0
-0.8
-2.2
0
0

cash-flows.row.sales-maturities-of-investments

065.522175.1
-2
-1.1
1.4
0
0.8
3.4
0
0
0
14.2

cash-flows.row.other-investing-activites

081.7243.9-64.5
71.8
6.2
2.4
-82
-90.7
-29.4
6.3
-143
4.5
54.6

cash-flows.row.net-cash-used-for-investing-activites

0-2981.8-249.1-260.3
-445
-1246.5
-781.9
-582.5
-90.8
-113.9
-90.4
-295.2
-1999.8
-182.6

cash-flows.row.debt-repayment

0-3.2-88.1-236.9
-113
-312.9
0
0
0
-112
-222
-220.2
0
0

cash-flows.row.common-stock-issued

01.44.33
1.8
1.1
0
468.2
0
0
0
300
0
0

cash-flows.row.common-stock-repurchased

0-62.8313247.4
150.2
312.9
0
0
0
0
0
-95.5
0
0

cash-flows.row.dividends-paid

0-125.4-118.6-79.8
-105.2
-80.5
-76
-46.1
-26.6
-17.5
-40.1
-28.6
-12.1
-0.8

cash-flows.row.other-financing-activites

0-68-384.4-196.8
-319.3
-351.6
55.3
-1096.1
-589.5
-233.8
-69.2
-96.5
1011.5
301.7

cash-flows.row.net-cash-used-provided-by-financing-activities

0-258-273.8-263.1
-385.5
-430.9
-20.7
-674
-616.1
-363.3
-331.4
-45.4
999.4
301

cash-flows.row.effect-of-forex-changes-on-cash

0126.654.3-19
17.5
11.1
28.2
3.9
-50
-40.5
-145.1
-89
0
0

cash-flows.row.net-change-in-cash

688.28-1709.3754.41092.5
596
-380.7
536.2
-177.6
220.6
19.6
-11.2
-18.3
-94.9
130.1

cash-flows.row.cash-at-end-of-period

4805.74964.22673.61919.2
826.6
230.6
611.3
75.4
263.1
42.5
23
34.2
53.9
148.8

cash-flows.row.cash-at-beginning-of-period

4117.462673.61919.2826.6
230.6
611.3
75
253
42.5
23
34.2
52.5
148.8
18.7

cash-flows.row.operating-cash-flow

688.281403.61222.91628.9
1409
1285.7
1159.8
1073.5
977.5
537.3
555.7
411.2
905.5
11.8

cash-flows.row.capital-expenditure

0-381.8-281.8-195.8
-506.5
-123.9
-109.5
-118.3
-98.2
-126.1
-95.9
-312.4
-2004.3
-251.4

cash-flows.row.free-cash-flow

688.281021.8941.11433.1
902.5
1161.8
1050.2
955.2
879.3
411.3
459.7
98.9
-1098.8
-239.7

Income Statement Row

Advanced Enzyme Technologies Limited's revenue saw a change of 0.057% compared with the previous period. The gross profit of ADVENZYMES.NS is reported to be 4088.33. The company's operating expenses are 2874.19, showing a change of 19.306% from the last year. The expenses for depreciation and amortization are 350.29, which is a 0.001% change from the last accounting period. Operating expenses are reported to be 2874.19, which shows a 19.306% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.186% year-over-year growth. The operating income is 1256.81, which shows a -0.245% change when compared to the previous year. The change in the net income is -0.117%. The net income for the last year was 1056.39.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010

income-statement-row.row.total-revenue

6047.635406.452895004.5
4415.6
4177.4
3879.1
3301.1
2926.5
2221.2
2145.3
2194.4
1712.6
1161.1

income-statement-row.row.cost-of-revenue

1426.3113181194.31055.9
871.9
814
890.6
756.6
682.7
554.2
557.1
609.1
550.5
531.5

income-statement-row.row.gross-profit

4621.324088.34094.73948.5
3543.7
3363.3
2988.6
2544.5
2243.7
1666.9
1588.2
1585.3
1162.2
629.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

216.59---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

246.36---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

63.96---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

382.43254.645.729.8
41.3
46.4
7.9
19.2
4.1
17.5
1
11.2
15.9
1.9

income-statement-row.row.operating-expenses

3033.112874.22409.11851.2
1751.8
1715.7
1510.6
1144.7
932.9
842.6
882.9
741.8
580.2
441.7

income-statement-row.row.cost-and-expenses

4459.424192.23603.42907.2
2623.7
2529.7
2401.2
1901.3
1615.6
1396.8
1440
1350.9
1130.6
973.3

income-statement-row.row.interest-income

19.111.245.8
3.6
3.5
1.9
3.5
4.6
4.4
5.9
19.4
8.5
5.8

income-statement-row.row.interest-expense

26.924.21815.9
25.8
38.6
47.2
39
66.7
79.6
89.3
90.4
117.1
21.5

income-statement-row.row.selling-and-marketing-expenses

63.96---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-0.78147.145.765
22.1
-16.5
-88.3
-33.9
-129
-76.3
-420.7
-70.3
-106.2
3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

382.43254.645.729.8
41.3
46.4
7.9
19.2
4.1
17.5
1
11.2
15.9
1.9

income-statement-row.row.total-operating-expenses

-0.78147.145.765
22.1
-16.5
-88.3
-33.9
-129
-76.3
-420.7
-70.3
-106.2
3

income-statement-row.row.interest-expense

26.924.21815.9
25.8
38.6
47.2
39
66.7
79.6
89.3
90.4
117.1
21.5

income-statement-row.row.depreciation-and-amortization

344.14350.3349.8284.1
257.8
211.2
183
122.1
87.2
90.2
99.8
74.3
55
49.8

income-statement-row.row.ebitda-caps

2314.79---
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

1903.911256.81664.82036.3
1769.5
1636.1
1478
1399.8
1310.8
824.3
705.3
843.5
582
187.9

income-statement-row.row.income-before-tax

1903.131403.91710.62103.7
1791.6
1619.6
1389.7
1365.8
1181.8
748.1
284.5
773.2
475.8
190.9

income-statement-row.row.income-tax-expense

511.2365.2472.6589.1
461.1
460.6
454.1
442.2
414.3
230
74.5
264.5
134.9
22.2

income-statement-row.row.net-income

1371.161056.41195.81459.3
1292.9
1110.6
900.5
906.5
758.5
509.8
197.4
498.2
337.5
166.7

Frequently Asked Question

What is Advanced Enzyme Technologies Limited (ADVENZYMES.NS) total assets?

Advanced Enzyme Technologies Limited (ADVENZYMES.NS) total assets is 14218470000.000.

What is enterprise annual revenue?

The annual revenue is 3187770000.000.

What is firm profit margin?

Firm profit margin is 0.764.

What is company free cash flow?

The free cash flow is 6.162.

What is enterprise net profit margin?

The net profit margin is 0.227.

What is firm total revenue?

The total revenue is 0.315.

What is Advanced Enzyme Technologies Limited (ADVENZYMES.NS) net profit (net income)?

The net profit (net income) is 1056390000.000.

What is firm total debt?

The total debt is 334990000.000.

What is operating expences number?

The operating expences are 2874190000.000.

What is company cash figure?

Enretprise cash is 0.000.